Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Simulations Plus, Inc.

< Previous 1 2 3 4 Next >
Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus and the University of Bath Awarded New FDA Grant
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Extends Collaboration with Major Toxicology Research Agency
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Launches Corporate Development Initiative
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Participate in Upcoming Healthcare Conferences
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases GastroPlus® Version 9.9
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports First Quarter Fiscal 2024 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Outlines Paths to Win at 2023 Investor Day
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
ISoP New Board of Trustees Members Announced
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Host Investor Day on Tuesday, November 14th
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Receives New FDA Grant Award
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases ADMET Predictor® 11
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback